Open Orphan PLC (LON:ORP) said its hVIVO operation has officially launched its Disease in Motion platform, a collation of clinical, immunological and virological biomarkers as well as information taken from wearable technology.
Data from multiple infectious disease types is likely to be used by big tech, wearables, pharma and biotech companies, investors were told.
Chairman Cathal Friel said: “The Disease in Motion platform includes data from cutting edge wearables that are applicable to a wide variety of end users including big tech, wearables, pharma and biotech companies.
“As volunteers remain under close observation prior to viral challenge, during disease progression and until resolution, data is captured across the full time-course of the infection, yielding possible insights into the body’s response to infection.
“The Disease in Motion platform currently spans several conditions with plans to expand this going forward.”